Your browser doesn't support javascript.
loading
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial.
Walsh, Mary-Claire R; Alam, Mohammed Shafiul; Pierce, Kristen K; Carmolli, Marya; Alam, Masud; Dickson, Dorothy M; Bak, Dan M; Afreen, Sajia; Nazib, Forida; Golam, Kibria; Qadri, Firdausi; Diehl, Sean A; Durbin, Anna P; Whitehead, Stephen S; Haque, Rashidul; Kirkpatrick, Beth D.
Affiliation
  • Walsh MR; UVM Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT, USA; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Alam MS; Infectious Diseases Division, iccdr,b, Dhaka, Bangladesh.
  • Pierce KK; UVM Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT, USA; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Carmolli M; UVM Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Alam M; Infectious Diseases Division, iccdr,b, Dhaka, Bangladesh.
  • Dickson DM; UVM Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Bak DM; UVM Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Afreen S; Infectious Diseases Division, iccdr,b, Dhaka, Bangladesh.
  • Nazib F; UVM Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Golam K; Infectious Diseases Division, iccdr,b, Dhaka, Bangladesh.
  • Qadri F; Infectious Diseases Division, iccdr,b, Dhaka, Bangladesh.
  • Diehl SA; UVM Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Durbin AP; Johns Hopkins School of Public Health, Baltimore, MD, USA.
  • Whitehead SS; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Haque R; Infectious Diseases Division, iccdr,b, Dhaka, Bangladesh.
  • Kirkpatrick BD; UVM Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT, USA; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA. Electronic address: beth.kirkpatrick@med.uvm.edu.
Lancet Infect Dis ; 24(2): 150-160, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37776876
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dengue / Dengue Virus / Dengue Vaccines Type of study: Clinical_trials / Guideline Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Asia Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dengue / Dengue Virus / Dengue Vaccines Type of study: Clinical_trials / Guideline Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Asia Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: Country of publication: